Gene-editing techniques could soon allow researchers to replace entire genes and engineer complex cellular circuits — if the ...

Shares of Codexis climbed after the company said it reached an agreement with an undisclosed siRNA drugmaker. The stock rose 4%, to $1.37, in premarket trading Monday. Through Friday's close, shares ...

A tiny molecular scissor that once barely worked in human cells has been transformed into a high-performance genome-editing ...

Prime Medicine receives FDA IND clearance for PM647, a one-time gene editing therapy for alpha-1 antitrypsin deficiency.

Stacker combed IMDb and Metacritic data to compile a list of the 100 worst rom-coms of all time, from "Mannequin" to ...